Representation of American blacks in clinical trials of new drugs
Author:
- C. K. SvenssonCSC. K. Svensson
- 13 January 1989
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 261 (2) , 263-265
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Biologic determinants of propranolol disposition: Results from 1308 patients in the beta-blocker heart attack trial*Clinical Pharmacology & Therapeutics, 1985
- Blood pressure, plasma volume, and catecholamine levels during enalapril therapy in blacks with hypertensionClinical Pharmacology & Therapeutics, 1984
- Responses to captopril and hydrochlorothiazide in black patients with hypertensionClinical Pharmacology & Therapeutics, 1982
- Underrepresentation of Women in New Drug TrialsAnnals of Internal Medicine, 1981